<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39258390</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1360-046X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>British journal of neurosurgery</Title><ISOAbbreviation>Br J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Hyperostosis in meningioma: a retrospective exploration of histological correlates.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>7</EndPage><MedlinePgn>1-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02688697.2024.2400134</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Meningiomas are the most common type of primary brain tumour. Hyperostosis is commonly associated but remains incompletely understood. This study aimed to evaluate the relationship between meningioma-associated hyperostosis and other tumour variables.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">We retrospectively analysed 245 patients with 263 cranial meningiomas (202 CNS WHO grade 1, 53 grade 2, and 8 grade 3) who underwent surgery over a three-year period. Meningiomas adjacent to the skull were included. Demographic, radiological, and tumour characteristics were analysed using standard statistical methods.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hyperostosis was evident in 99 (38%) of meningiomas. The most common subtypes were meningothelial, transitional, fibrous, atypical, and anaplastic. There were no statistically significant relationships between hyperostosis and bone invasion, and CNS WHO grade and histological subtype. Hyperostosis was more common in skull base meningiomas than in convexity meningiomas (<i>p</i>&#x2009;=&#x2009;0.001). Ki-67 index was significantly related to CNS WHO grade but not histological subtype when grade was considered. Mean Ki-67 index was higher in meningiomas without hyperostosis (<i>p</i>&#x2009;=&#x2009;0.03). There was no such relationship with bone invasion (<i>p</i>&#x2009;=&#x2009;0.29). Univariate and multivariate analysis revealed that Ki-67 index was negatively correlated with hyperostosis (<i>p</i>&#x2009;=&#x2009;0.03), while bone invasion (<i>p</i>&#x2009;&lt;&#x2009;0.001) and skull base location (<i>p</i>&#x2009;=&#x2009;0.03) were positively correlated with hyperostosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Hyperostosis did not appear to be related to CNS WHO grade or histological subtype. Proliferative activity appeared to be higher in meningiomas without hyperostosis and hyperostosis was associated with evidence of bone invasion and skull base location.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>William H</ForeName><Initials>WH</Initials><Identifier Source="ORCID">0000-0001-7699-3342</Identifier><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Danyal Z</ForeName><Initials>DZ</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khellaf</LastName><ForeName>Abdelhakim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, University of Montreal, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsyben</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posa</LastName><ForeName>Marius</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorour</LastName><ForeName>Mo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budohoski</LastName><ForeName>Karol P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Mayen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allinson</LastName><ForeName>Kieren S J</ForeName><Initials>KSJ</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirollos</LastName><ForeName>Ramez W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmy</LastName><ForeName>Adel E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Neurosurg</MedlineTA><NlmUniqueID>8800054</NlmUniqueID><ISSNLinking>0268-8697</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain tumours</Keyword><Keyword MajorTopicYN="N">histology</Keyword><Keyword MajorTopicYN="N">hyperostosis</Keyword><Keyword MajorTopicYN="N">meningioma</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39258390</ArticleId><ArticleId IdType="doi">10.1080/02688697.2024.2400134</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>